Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA rejection
Pharma
Lexicon gets final FDA rejection for diabetes prospect
The company already moved to cut its commercial sales force following several FDA setbacks in its efforts to introduce sotagliflozin in diabetes.
Zoey Becker
Dec 23, 2024 11:20am
J&J, AZ approval filings rejected by FDA
Dec 17, 2024 10:02am
Lexicon steps out of commercial space after FDA setbacks
Nov 22, 2024 11:46am
FDA shoots down Intercept's bid for full approval of Ocaliva
Nov 12, 2024 2:12pm
Zealand's hypoglycemia med rebuffed again by FDA
Oct 9, 2024 9:19am
Novo won't file for IcoSema approval in US
Aug 13, 2024 1:40pm
